# Roivant Sciences Ltd. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/roivant-sciences-ltd | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 34 | | Claims under review | 2 | | Evidence records | 12 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:23.017038+00:00 | | Last reviewed | 2026-10-17T04:45:23.017038+00:00 | ## Identity - Legal name: Roivant Sciences Ltd. - Display name: Roivant Sciences Ltd. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T06:56:46.947931+00:00 | | Completeness | 0.409 | | Record Quality | 0.819 | | Directors | 9 | | Committees | 7 | | Governance events | 22 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Daniel Gold: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:7 - Ilan Oren: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:8 - James C. Momtazee: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:9 - Keith Manchester: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Audit (member). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:10 - Matthew Gline: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:11 - Mayukh Sukhatme: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:12 - Meghan FitzGerald: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:13 - Melissa Epperly: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:14 - Mayukh Sukhatme: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Compensation (member). claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_record:28 ## Committees - Audit (audit). Chair: Melissa Epperly. Members: Melissa Epperly (chair, current); Keith Manchester (member, current); Meghan FitzGerald (member, current). committee_id=alpha:committee:roivant-sciences-ltd:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Melissa Epperly (member, current). committee_id=alpha:committee:roivant-sciences-ltd:audit-chair - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Meghan FitzGerald (member, current). committee_id=alpha:committee:roivant-sciences-ltd:audit-nominating-and-governance - Compensation (compensation). Chair: Daniel Gold. Members: Daniel Gold (chair, current); Ilan Oren (member, current); Mayukh Sukhatme (member, current). committee_id=alpha:committee:roivant-sciences-ltd:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Daniel Gold (member, current). committee_id=alpha:committee:roivant-sciences-ltd:compensation-chair - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Ilan Oren (member, current). committee_id=alpha:committee:roivant-sciences-ltd:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Ilan Oren. Members: Ilan Oren (chair, current); James C. Momtazee (member, current); Meghan FitzGerald (member, current). committee_id=alpha:committee:roivant-sciences-ltd:nominating-and-governance ## Executive leadership - Eric Venker: President and Immunovant CEO [CEO]. Status: current. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:15 - Frank Torti: President and Vant Chair [PRESIDENT]. Status: current. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:16 - Jennifer Humes: Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:19 - Richard Pulik: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:23 - Huafeng Xu: Chief Technology Officer [CTO]. Status: unknown. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:17 - Ian Rosenblum: Chief Information Officer [CIO]. Status: unknown. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:18 - Josh Chen: General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:20 - Matthew Gline: Chief Executive Officer & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:21 - Mayukh Sukhatme: President, Chief Investment Officer & Director [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:22 ## Governance events - CEO_CHANGED: Eric Venker executive of Roivant Sciences Ltd., effective 2025-07-29. Effective: 2025-07-29. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:f6az7r1p6z1d9 - EXECUTIVE_APPOINTED: Frank Torti executive of Roivant Sciences Ltd., effective 2025-07-29. Effective: 2025-07-29. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:fs6g0x1momndj - EXECUTIVE_APPOINTED: Jennifer Humes executive of Roivant Sciences Ltd., effective 2025-07-29. Effective: 2025-07-29. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1l6jn6hzikv1l - CFO_CHANGED: Richard Pulik executive of Roivant Sciences Ltd., effective 2025-07-29. Effective: 2025-07-29. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:lre4njyv7nt - DIRECTOR_APPOINTED: Mayukh Sukhatme seat on Roivant Sciences Ltd., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:kpk5mj1lbuixz - DIRECTOR_APPOINTED: Meghan FitzGerald seat on Roivant Sciences Ltd., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:vmk834porbgi - COMMITTEE_CREATED: Audit; Nominating and Governance committee of Roivant Sciences Ltd., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1dfvuf01ugn462 - COMMITTEE_MEMBER_ADDED: Meghan FitzGerald member of Audit; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:15znr5n1wpg6xf - DIRECTOR_APPOINTED: Melissa Epperly seat on Roivant Sciences Ltd., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1yd7u581j9wdfk - COMMITTEE_CREATED: Audit · Chair committee of Roivant Sciences Ltd., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:suw4l01pj4dgw - COMMITTEE_MEMBER_ADDED: Melissa Epperly member of Audit · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:10mygq91y3kqqr - DIRECTOR_APPOINTED: James C. Momtazee seat on Roivant Sciences Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:119np0n17bfh5r - DIRECTOR_APPOINTED: Matthew Gline seat on Roivant Sciences Ltd., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:15fsrm81jp3d2y - COMMITTEE_MEMBER_ADDED: James C. Momtazee member of Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:z5qz3py4td91 - DIRECTOR_APPOINTED: Daniel Gold seat on Roivant Sciences Ltd., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:kbdr96ebhh1w - COMMITTEE_CREATED: Compensation · Chair committee of Roivant Sciences Ltd., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:15htb50flhvrk - COMMITTEE_MEMBER_ADDED: Daniel Gold member of Compensation · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:4dhiv01r14rbu - DIRECTOR_APPOINTED: Ilan Oren seat on Roivant Sciences Ltd., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:ng9xa2adjnuc - DIRECTOR_APPOINTED: Keith Manchester seat on Roivant Sciences Ltd., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1actuuhmfe2ft - COMMITTEE_MEMBER_ADDED: Keith Manchester member of Audit, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1y47p2i1q5h3cy - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Roivant Sciences Ltd., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:akeho21syf4jo - COMMITTEE_MEMBER_ADDED: Ilan Oren member of Compensation; Nominating and Governance · Chair, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1so49b2hqucx0 ## Scoped resources - `alpha://company/roivant-sciences-ltd` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record - `alpha://company/roivant-sciences-ltd/identity` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=identity - `alpha://company/roivant-sciences-ltd/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=corporate-structure - `alpha://company/roivant-sciences-ltd/board` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=board - `alpha://company/roivant-sciences-ltd/committees` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=committees - `alpha://company/roivant-sciences-ltd/leadership` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=leadership - `alpha://company/roivant-sciences-ltd/ownership` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=ownership - `alpha://company/roivant-sciences-ltd/financials` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=financials - `alpha://company/roivant-sciences-ltd/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=capital-structure - `alpha://company/roivant-sciences-ltd/compensation` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=compensation - `alpha://company/roivant-sciences-ltd/governance` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=governance - `alpha://company/roivant-sciences-ltd/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=shareholder-governance - `alpha://company/roivant-sciences-ltd/audit` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=audit - `alpha://company/roivant-sciences-ltd/legal` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=legal - `alpha://company/roivant-sciences-ltd/risk` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=risk - `alpha://company/roivant-sciences-ltd/cyber` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=cyber - `alpha://company/roivant-sciences-ltd/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=ai-governance - `alpha://company/roivant-sciences-ltd/agents` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=agents - `alpha://company/roivant-sciences-ltd/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=ecosystem - `alpha://company/roivant-sciences-ltd/events` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=events - `alpha://company/roivant-sciences-ltd/relationships` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=relationships - `alpha://company/roivant-sciences-ltd/assessments` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=assessments - `alpha://company/roivant-sciences-ltd/evidence` (contract): https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:melissa-epperly","name":"Melissa Epperly"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:keith-manchester","name":"Keith Manchester"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:meghan-fitzgerald","name":"Meghan FitzGerald"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:daniel-gold","name":"Daniel Gold"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:ilan-oren","name":"Ilan Oren"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mayukh-sukhatme","name":"Mayukh Sukhatme"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:ilan-oren","name":"Ilan Oren"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:james-c-momtazee","name":"James C. Momtazee"},"source_id":"board_seats"}` - Claim alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:meghan-fitzgerald","name":"Meghan FitzGerald"},"source_id":"board_seats"}` ## Leadership - Daniel Gold: Director, Compensation · Chair. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Ilan Oren: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:8. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - James C. Momtazee: Director, Nominating and Governance. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Keith Manchester: Director, Audit. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:10. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Matthew Gline: Director. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Mayukh Sukhatme: Director. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:12. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Meghan FitzGerald: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:13. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Melissa Epperly: Director, Audit · Chair. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:14. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227. - Eric Venker: President and Immunovant CEO. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:15. Valid from: 2025-07-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dbe7dd5f04a8c265574d37dd615aa0a97b6c3009c2648b293eeca651d2accb71. - Frank Torti: President and Vant Chair. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:16. Valid from: 2025-07-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ae5bb9e4393107736a4f9c424415584ab33b7d5b35a71cbb50e97c0170e068d. - Huafeng Xu: Chief Technology Officer. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:45908baf412cec94ad951efac9ef9e18b7a17c39470027dda347af9395fb6776. - Ian Rosenblum: Chief Information Officer. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0b71a24905b80e28e79676b5a59008c0fed631a49cdd1a4b8b975ff9da36fbb7. - Jennifer Humes: Chief Accounting Officer. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:19. Valid from: 2025-07-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80d06f962a2cb69b0081b1545ceb33287617d0fec9db70156c88898f495a04f8. - Josh Chen: General Counsel. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4f064025bdaf96e3efb6fd345e7a8dbb80997d93f68b197534acb18acb44cf1d. - Matthew Gline: Chief Executive Officer & Director. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9ce26c1accdd62a2f5402add0569fed4ca8d27b08c9bfd3306976213e2bc9e5d. - Mayukh Sukhatme: President, Chief Investment Officer & Director. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:49c06a3dd0b242746d97c12c9e27c10efacff2369a25d42172943635788da326. - Richard Pulik: Chief Financial Officer. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:leadership_role:23. Valid from: 2025-07-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f92b6ee0a4769962ccec47e6b1ff1bdf9a06dd1d652715c8dd52c3aafb193956. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Melissa Epperly; Members Melissa Epperly (Chair); Keith Manchester; Meghan FitzGerald. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Compensation: Chair Daniel Gold; Members Daniel Gold (Chair); Ilan Oren; Mayukh Sukhatme. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_record:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Nominating and Governance: Chair Ilan Oren; Members Ilan Oren (Chair); James C. Momtazee; Meghan FitzGerald. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Roivant Sciences Ltd.. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a97640b48889335a9ad339d218aaf58222249ca17bf824458fb1eed10ab69273. ## Entity Status - Public listing published. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a97640b48889335a9ad339d218aaf58222249ca17bf824458fb1eed10ab69273. ## Published Fact - US. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a97640b48889335a9ad339d218aaf58222249ca17bf824458fb1eed10ab69273. - Healthcare. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a97640b48889335a9ad339d218aaf58222249ca17bf824458fb1eed10ab69273. ## Committee Appointment - Melissa Epperly: chair, Audit. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Keith Manchester: member, Audit. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Meghan FitzGerald: member, Audit. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Daniel Gold: chair, Compensation. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Ilan Oren: member, Compensation. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Mayukh Sukhatme: member, Compensation. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Ilan Oren: chair, Nominating and Governance. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - James C. Momtazee: member, Nominating and Governance. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. - Meghan FitzGerald: member, Nominating and Governance. Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c. ## Security Listing - ROIV (NASDAQ). Claim: alpha:claim:company:ab8a0d28-cfb2-41eb-8c61-cee27e51e6b5:security_listing:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a97640b48889335a9ad339d218aaf58222249ca17bf824458fb1eed10ab69273. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a97640b48889335a9ad339d218aaf58222249ca17bf824458fb1eed10ab69273: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/roivant-sciences-ltd). - alpha:projection-evidence:document:4eae815729e2328a7a67df3d0da4040f8b524b6d045dc80844d6f25a097aa227: [Roivant Sciences DEF 14A 2025-07-29](https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm). - alpha:projection-evidence:document:dbe7dd5f04a8c265574d37dd615aa0a97b6c3009c2648b293eeca651d2accb71: [ROIV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm). - alpha:projection-evidence:document:8ae5bb9e4393107736a4f9c424415584ab33b7d5b35a71cbb50e97c0170e068d: [ROIV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm). - alpha:projection-evidence:document:45908baf412cec94ad951efac9ef9e18b7a17c39470027dda347af9395fb6776: [Roivant Sciences key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ROIV). - alpha:projection-evidence:document:0b71a24905b80e28e79676b5a59008c0fed631a49cdd1a4b8b975ff9da36fbb7: [Roivant Sciences key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ROIV). - alpha:projection-evidence:document:80d06f962a2cb69b0081b1545ceb33287617d0fec9db70156c88898f495a04f8: [ROIV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm). - alpha:projection-evidence:document:4f064025bdaf96e3efb6fd345e7a8dbb80997d93f68b197534acb18acb44cf1d: [Roivant Sciences key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ROIV). - alpha:projection-evidence:document:9ce26c1accdd62a2f5402add0569fed4ca8d27b08c9bfd3306976213e2bc9e5d: [Roivant Sciences key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ROIV). - alpha:projection-evidence:document:49c06a3dd0b242746d97c12c9e27c10efacff2369a25d42172943635788da326: [Roivant Sciences key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ROIV). - alpha:projection-evidence:document:f92b6ee0a4769962ccec47e6b1ff1bdf9a06dd1d652715c8dd52c3aafb193956: [ROIV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm). - alpha:projection-evidence:9566e1b9aea24dd9164418ac8894ce877dd0544d2df975ddb2c3c6485a947b2c: [Audit](https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/roivant-sciences-ltd) - [Public Markdown](https://registry.alpha.ac/companies/roivant-sciences-ltd.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/roivant-sciences-ltd?format=jsonld) - MCP resource: `alpha://companies/roivant-sciences-ltd` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T06:56:46.69964+00:00; recorded 2026-10-17T06:56:46.69964+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.